Sweetch offers an AI-powered Continuous Glucose Monitoring (CGM) engagement platform for Type 2 Diabetes. Its hyper-personalized recommendations, delivered with emotional intelligence, aim to increase treatment adherence and improve health outcomes for individuals with chronic conditions. The platform serves healthcare organizations, including pharma, medical devices, payers, and providers, by turning data insights into actionable engagement strategies.